Skip to content
MarketScale
‹ Back to IndustriesHealthcare

NIH Puts New Clinical Trial Guidelines Into Effect

Researchers requesting funding for clinical trials must determine if their research meets new criteria set by new NIH guidelines. The new guidelines breaks from the traditional understanding to also  include both basic biomedical research and basic social and behavioral research. The switch has caused somewhat of a controversy, with some researchers claiming that the guidelines…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Researchers requesting funding for clinical trials must determine if their research meets new criteria set by new NIH guidelines. The new guidelines breaks from the traditional understanding to also include both basic biomedical research and basic social and behavioral research.

The switch has caused somewhat of a controversy, with some researchers claiming that the guidelines are too broad, and the new policies will increase researcher burdens. In September, more than 3500 scientists signed an open letter requesting NIH to delay the policy. Researchers conducting trials are now required to register and report results on ClinicalTrials.gov, but, if researchers impacted by the change do not select a funding opportunity that supports clinical trials when they apply to NIH, their grant is subjected to be rejected without a review.

Though some clarification from NIH in recent months has quelled many of the concerns expressed, some researchers have lingering doubts. “There’s still a problem, but the problem is less dire than the original set of concerns that we had,” says cognitive psychologist Jeremy Wolfe of the Harvard University.[1]

The guidelines go into effect on January 25th.

[1]

http://www.sciencemag.org/news/2018/01/nih-s-new-clinical-trial-policy-kicks-despite-concerns-basic-behavioral-researchers

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Two Radiology Deals Signal Focus on Coverage, Not Scanners

Colorado Imaging Associates and TRA Medical Imaging announced Sept. 8, 2026 that they are forming Affiliated Radiology to expand physician coverage for a shared health system client, Radiology Business reported. Separately, Align Capital Partners said in late May 2026 it agreed to acquire Boise-based Heritage Imaging, a mobile diagnostic imaging provider operating in 14 states, according to Radiology Business.

  • 01Affiliated Radiology was formed by combining Colorado Imaging Associates and TRA Medical Imaging to expand physician coverage for a shared health system client.
  • 02Heritage Imaging operates mobile diagnostic units across 14 states, providing PET-CT, MRI, nuclear medicine, ultrasound and echocardiography to critical access hospitals and community clinics.
  • 03Health system sourcing teams should request service-level commitments, credentialing procedures, cross-location read routing, and PACS/RIS/EHR integration details before contracting with coverage-focused or mobile imaging arrangements.

Sep 12, 2026

Dr. Sotirios Stathakis: A TheraPanacea Customer Interview

Dr. Sotirios Stathakis: A TheraPanacea Customer Interview

Dr. Sotirios Stathakis, Chief of Physics at Mary Bird Perkins Cancer Center, discusses how the facility integrated TheraPanacea's AI tools including MRI Box and Annotate to streamline workflows and improve treatment planning. The implementation, which began in 2023, demonstrates how thoughtful AI adoption enhances quality assurance and operational efficiency in cancer care.

  • 01MRI-only workflow adoption via MRI Box reduces need for CT scans, particularly for prostate and bladder cancer treatment
  • 02Annotate tool used in 40-45% of cases for head, neck, and abdominal procedures, offering precision beyond manual contouring
  • 03AI implementation strategy: start with control cases, build team confidence, then gradually expand to ensure smooth adoption and staff acceptance

Sep 11, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz, Chief Medical Physicist at Texas Oncology, brings both professional expertise and personal experience as a breast cancer survivor to her role in advancing cancer care. Over 23 years at Texas Oncology, she champions technology adoption and AI integration in oncology while emphasizing the importance of human oversight in clinical applications.

  • 01Dr. Rosencranz is a five-year breast cancer survivor whose personal experience informs her approach to patient empathy and personalized care delivery.
  • 02AI applications in oncology like auto-contouring and treatment planning show significant advancement potential, but require consistent human leadership and oversight.
  • 03Texas Oncology reaches many demographics, including rural areas where travel to urban centers is hard, while staying current with the highest technology available.

Sep 11, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512